Extendicare Stock Investor Sentiment
| EXE Stock | CAD 26.58 2.47 10.24% |
About 51% of Extendicare's investors are presently thinking to get in. The analysis of overall sentiment of trading Extendicare stock suggests that some investors are interested at this time. Extendicare's investing sentiment overview a quick insight into current market opportunities from investing in Extendicare. Many technical investors use Extendicare stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Extendicare |
Extendicare stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Extendicare earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Extendicare that are available to investors today. This information is accessible both publicly - through Extendicare's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Extendicare-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Extendicare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Extendicare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Extendicare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Extendicare alpha.
Extendicare Largest EPS Surprises
Earnings surprises can significantly impact Extendicare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-11-08 | 2018-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2018-08-09 | 2018-06-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2013-08-08 | 2013-06-30 | 0.05 | 0.04 | -0.01 | 20 | ||
2015-05-07 | 2015-03-31 | 0.03 | 0.01 | -0.02 | 66 | ||
2004-05-06 | 2004-03-31 | 0.18 | 0.21 | 0.03 | 16 | ||
1999-11-12 | 1999-09-30 | -0.05 | -0.08 | -0.03 | 60 |
There is far too much social signal, news, headlines, and media speculation about Extendicare that are available to investors today. This information is accessible both publicly - through Extendicare's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Extendicare-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Extendicare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Extendicare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Extendicare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Extendicare alpha.
Extendicare Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Cormark Raises Extendicare Price Target to C30.00 - MarketBeat | 12/04/2025 |
2 | Extendicare Independent Director Acquires 663 percent More Stock - simplywall.st | 12/09/2025 |
3 | Extendicare Shares Little Changed in TSX Trade Session - Kalkine Media | 12/15/2025 |
4 | EXTENDICARE INC CDA To Go Ex-Dividend On December 31st, 2025 With 0.03048 USD Dividend Per Share - | 12/30/2025 |
5 | Public market insider selling at Extendicare - The Globe and Mail | 01/12/2026 |
6 | Extendicare Sets Date for Q4 2025 Results and Investor Call - TipRanks | 01/16/2026 |
7 | Extendicare Inc. Looks Interesting, And Its About To Pay A Dividend - Yahoo Finance | 01/27/2026 |
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.
